季刊
2095-882X
anti-CD20monoclonalantibodiesAPRILbiologicalagentsBLyScomplementIgAnephropathy
economicevaluationnonpharmacologicalinterventionspre-diabetesprevention
diabetesmellitusinsulininjectionlipohypertrophylocalizedinsulin-derivedamyloidosis
C-reactiveproteintoalbuminratioinflammation:biomarkerlungcancerprognosis
essentialtremorMRgFUSParkinson'sdiseaseproctortelemedicine
dosimetryhypofractionationmagneticresonanceimagingprostatecancerradiationdoseradiotherapy
bortezomiblightchainsubtypemultiplemyelomaresponseassessment